Glancy Prongay Seeks To Represent Blood Clot Co. Investors
Glancy Prongay & Murray LLP on Monday sought to represent a proposed class of investors in a proposed securities fraud class action accusing biotechnology company Portola Pharmaceuticals Inc. of not properly...To view the full article, register now.
Already a subscriber? Click here to view full article